Development of Itaconate Polymers Microparticles for Intracellular Regulation of Pro‐Inflammatory Macrophage Activation
Open Access
- 4 April 2025
- journal article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (13) , e2405257
Abstract
Itaconate (IA) is an endogenous metabolite and a potent regulator of the innate immune system. It's use in immunomodulatory therapies has faced limitations due to challenges in controlled delivery and requirements of high extracellular concentrations for internalization of the highly polar small molecule to achieve its intracellular therapeutic activity. Microparticle (MP)‐based delivery strategies are a promising approach for intracellular delivery of small molecule metabolites through macrophage phagocytosis and subsequent intracellular polymer degradation‐based delivery. Toward the goal of intracellular delivery of IA, degradable polyester polymer‐ (poly(dodecyl itaconate)) based IA polymer microparticles (IA‐MPs) are generated using an emulsion method, forming micron‐scale (≈1.5 µm) degradable microspheres. IA‐MPs are characterized with respect to their material properties and IA release kinetics to inform particle fabrication. Treatment of murine bone marrow‐derived macrophages with an optimized particle concentration of 0.1 mg million−1 cells enables phagocytosis‐mediated internalization and low levels of cytotoxicity. Flow cytometry demonstrates IA‐MP‐specific regulation of IA‐sensitive inflammatory targets. Metabolic analyses demonstrate that IA‐MP internalization inhibits oxidative metabolism and induced glycolytic reliance, consistent with the established mechanism of IA‐associated inhibition of succinate dehydrogenase. This development of IA‐based polymer microparticles provides a basis for additional innovative metabolite‐based microparticle drug delivery systems for the treatment of inflammatory disease.Keywords
All Related Versions
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (01AR078343)
- National Institute of Allergy and Infectious Diseases (R01AI155907)
This publication has 82 references indexed in Scilit:
- Itaconate: A Potent Macrophage ImmunomodulatorInflammation, 2023
- Alpha‐ketoglutaric acid based polymeric particles for cutaneous wound healingJournal of Biomedical Materials Research Part A, 2023
- Macrophage Immunomodulation Through New Polymers that Recapitulate Functional Effects of Itaconate as a Power House of Innate ImmunityAdvanced Functional Materials, 2020
- Recent advances in the formulation of PLGA microparticles for controlled drug deliveryProgress in Biomaterials, 2020
- Biomaterial-mediated reprogramming of monocytes via microparticle phagocytosis for sustained modulation of macrophage phenotypeActa Biomaterialia, 2020
- Synthesis of degradable-polar-hydrophobic-ionic co-polymeric microspheres by membrane emulsion photopolymerization: In vitro and in vivo studiesActa Biomaterialia, 2019
- Modulation of macrophage phenotype via phagocytosis of drug‐loaded microparticlesJournal of Biomedical Materials Research Part A, 2019
- A high-throughput microparticle microarray platform for dendritic cell-targeting vaccinesBiomaterials, 2009
- Development of highly porous large PLGA microparticles for pulmonary drug deliveryBiomaterials, 2009
- In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapyJournal of Biomedical Materials Research, 1994